Netflix (NASDAQ:NFLX) stock Analyst Ratings

/ / Consumer Discretionary /

Netflix (NASDAQ:NFLX) stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 11.86% Morgan Stanley $475 → $550 Maintains Overweight 10/19/2023 -3.4% Morgan Stanley $430 → $475 Upgrades Equal-Weight → Overweight 10/19/2023 -2.38% JP Morgan $455 → $480 Maintains Overweight 10/19/2023 -6.45% Guggenheim → $460 Reiterates Buy → Buy 10/19/2023 6.77% Wedbush → $525 Reiterates Outperform → Outperform 10/19/2023 -5.43% Truist Securities $430 → $465 Upgrades Hold → Buy 10/19/2023 -3.4% Oppenheimer $470 → $475 Maintains Outperform 10/19/2023 -17.84% Rosenblatt $400 → $404 Maintains Neutral 10/19/2023 3.72% Keybanc → $510 Upgrades Sector Weight → Overweight 10/17/2023 -12.55% Truist Securities $485 → $430 Maintains Hold 10/16/2023 -33.9% Benchmark → $325 Reiterates Sell → Sell 10/13/2023 — Wolfe Research Downgrades Outperform → Peer Perform 10/11/2023 -18.65% Piper Sandler $440 → $400 Maintains Neutral 10/11/2023 -12.55% Morgan Stanley $450 → $430 Maintains Equal-Weight 10/09/2023 -20.68% Goldman […]

Netflix (NASDAQ:NFLX) stock Analyst Ratings Read Post »

Roku Analyst Turns Bearish, Believes This Revenue Growth Driver Is ‘Less Economic’

/ / Telecommunications /

The company has been facing headwinds in advertising growth, with streaming giants Disney+ (NYSE:DIS) and Netflix (NASDAQ:NFLX) launching ad tiers and from a broader spending pullback in media and entertainment, according to Seaport Research Partners. The Roku Analyst: David Joyce downgraded the rating for Roku from Neutral to Sell, while establishing a price target of $75. The Roku Thesis: With some improvement in industry digital ad growth expectations for the fourth quarter of 2023 and full-year 2024, this is higher than “our estimates for Roku, implying that the company could be losing share,” Joyce said in the downgrade note. Check out other analyst stock ratings. “While Roku still has ~$2.0B of cash on hand, which is plenty of cushion to handle our expectation of 4Q23E cash burn of $216MM and another $53MM next year, we think the business model is entering a more mature growth phase,” the analyst wrote. “While Roku still benefits from its

Roku Analyst Turns Bearish, Believes This Revenue Growth Driver Is ‘Less Economic’ Read Post »

Apple to Halt Watch Sales as It Prepares to Comply With U.S. Import Ban

/ / Technology /

Apple is set to halt sales of its smartwatch in the coming days as the company prepares to comply with a U.S. import ban stemming from a federal trade ruling over a blood-oxygen sensor on some versions of the device. The October ruling gave the Biden administration 60 days to review the decision, in which the U.S. International Trade Commission found that Apple violated patents in most new models of the Apple Watch since 2020. Apple said it is stopping watch sales to take pre-emptive steps in case the ruling stands. The ban would include the Apple Watch Series 9 and Apple Watch Ultra 2, the company said. “Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers,” the company said. The case revolves around medical-technology company Masimo, which alleged in a 2021 complaint that

Apple to Halt Watch Sales as It Prepares to Comply With U.S. Import Ban Read Post »

CFRA Maintains Buy Opinion On Shares Of Adobe Inc.

/ / Technology /

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: ADBE terminated its intent to acquire Figma, citing that there is no clear path to receive regulatory approval from the European Commission and the U.K. Competition and Markets Authority (CMA). We’re by no means surprised by the decision as we thought the regulatory hurdles across the globe were too steep to overcome; we note that the termination includes a $1B fee that ADBE will pay. Still, this provides clarity on the subject matter with the deal being stuck in limbo for the last 15 months (valued at $20B half cash/stock). Despite hopes that the M&A landscape could be improving, with completed mega deals of Microsoft/Activision and Broadcom/VMware, we think regulators continue to scrutinize Tech deals, especially as we progress into a more AI-driven environment. Europe and the

CFRA Maintains Buy Opinion On Shares Of Adobe Inc. Read Post »

General Electric (NYSE:GE) Stock Analyst Ratings

/ / Industrials /

General Electric (NYSE:GE) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 21.49% RBC Capital $131 → $150 Maintains Outperform 12/15/2023 16.63% Wells Fargo $115 → $144 Upgrades Equal-Weight → Overweight 12/11/2023 19.87% Citigroup $135 → $148 Maintains Buy 10/25/2023 6.1% RBC Capital $130 → $131 Maintains Outperform 10/25/2023 7.72% Barclays $131 → $133 Maintains Overweight 09/28/2023 14.2% Deutsche Bank → $141 Initiates Coverage On → Buy 08/10/2023 1.24% Morgan Stanley $122 → $125 Maintains Overweight 07/31/2023 — Oppenheimer Downgrades Outperform → Perform 07/27/2023 9.34% Citigroup $126 → $135 Maintains Buy 07/26/2023 5.29% Argus Research $112 → $130 Maintains Buy 07/26/2023 -1.19% Morgan Stanley $110 → $122 Maintains Overweight 07/26/2023 5.29% RBC Capital $120 → $130 Maintains Outperform 07/26/2023 6.1% Barclays $125 → $131 Maintains Overweight 07/26/2023 7.72% Goldman Sachs $121 → $133 Maintains Buy 07/11/2023 2.05% Citigroup $114 → $126 Maintains

General Electric (NYSE:GE) Stock Analyst Ratings Read Post »

Roku, Inc. (NASDAQ: ROKU) Stock Analyst Ratings

/ / Telecommunications /

Roku, Inc. (NASDAQ: ROKU) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 -20.25% Seaport Global → $75 Downgrades Neutral → Sell 12/15/2023 -29.82% MoffettNathanson $64 → $66 Downgrades Neutral → Sell 11/27/2023 23.35% Cannonball Research → $116 Upgrades Neutral → Buy 11/02/2023 6.34% Susquehanna $95 → $100 Maintains Positive 11/02/2023 -20.25% Pivotal Research $58 → $75 Upgrades Sell → Hold 10/31/2023 -41.51% MoffettNathanson → $55 Upgrades Sell → Neutral 10/23/2023 -25.56% Truist Securities $80 → $70 Maintains Hold 10/11/2023 -13.87% Piper Sandler $90 → $81 Maintains Neutral 10/06/2023 — Seaport Global Initiates Coverage On → Neutral 09/28/2023 -17.06% Citigroup $100 → $78 Maintains Neutral 09/27/2023 — Raymond James Reinstates → Market Perform 09/07/2023 6.34% JP Morgan $95 → $100 Maintains Overweight 09/07/2023 8.46% DA Davidson $100 → $102 Maintains Buy 09/07/2023 6.34% Wedbush $93 → $100 Maintains Outperform 09/07/2023 1.02% Susquehanna

Roku, Inc. (NASDAQ: ROKU) Stock Analyst Ratings Read Post »

Salesforce (NYSE:CRM) Analyst Ratings

/ / Technology /

Salesforce (NYSE:CRM) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 18.64% Wolfe Research → $315 Upgrades Peer Perform → Outperform 12/01/2023 9.22% Argus Research $275 → $290 Maintains Buy 11/30/2023 9.22% Evercore ISI Group $275 → $290 Maintains Outperform 11/30/2023 12.99% Raymond James $280 → $300 Maintains Strong Buy 11/30/2023 12.99% Stifel $275 → $300 Maintains Buy 11/30/2023 3.57% Truist Securities → $275 Reiterates Buy → Buy 11/30/2023 -2.08% JP Morgan $240 → $260 Maintains Overweight 11/30/2023 10.35% JMP Securities $275 → $293 Maintains Market Outperform 11/30/2023 5.46% Mizuho $255 → $280 Maintains Buy 11/30/2023 3.57% Oppenheimer $250 → $275 Maintains Outperform 11/30/2023 4.33% BMO Capital $252 → $277 Maintains Outperform 11/30/2023 9.22% Morgan Stanley $278 → $290 Maintains Equal-Weight 11/30/2023 7.34% RBC Capital $240 → $285 Maintains Outperform 11/30/2023 5.46% Wedbush $255 → $280 Maintains Outperform 11/30/2023 5.46% Wells Fargo $265

Salesforce (NYSE:CRM) Analyst Ratings Read Post »

Royal Bank of Canada (NYSE:RY) Analyst Ratings

/ / Financials /

Royal Bank of Canada (NYSE:RY) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 — B of A Securities Upgrades Neutral → Buy 08/25/2023 39.87% Credit Suisse $138 → $139 Maintains Outperform 08/25/2023 26.79% Barclays $124 → $126 Maintains Underweight 08/21/2023 24.77% Barclays $122 → $124 Maintains Underweight 06/06/2022 25.78% Argus Research $121 → $125 Maintains Buy 03/02/2021 25.78% B of A Securities → $125 Downgrades Buy → Neutral 03/01/2021 0.62% Argus Research $92 → $100 Maintains Buy 05/13/2020 -1.39% B of A Securities $70 → $98 Maintains Buy 03/25/2020 -30.57% CFRA $83 → $69 Maintains Hold 02/24/2020 12.7% Credit Suisse $111 → $112 Maintains Outperform

Royal Bank of Canada (NYSE:RY) Analyst Ratings Read Post »

ARM Holdings (NASDAQ:ARM) Analyst Ratings

/ / Technology /

ARM Holdings (NASDAQ:ARM) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 0.72% Deutsche Bank $60 → $70 Downgrades Buy → Hold 11/20/2023 0.72% Wells Fargo → $70 Initiates Coverage On → Overweight 11/10/2023 -20.86% Morgan Stanley → $55 Initiates Coverage On → Equal-Weight 10/18/2023 -6.47% Keybanc → $65 Initiates Coverage On → Overweight 10/10/2023 -9.35% Daiwa Capital → $63 Initiates Coverage On → Buy 10/09/2023 -0.72% Loop Capital → $69 Initiates Coverage On → Buy 10/09/2023 22.3% Rosenblatt → $85 Initiates Coverage On → Buy 10/09/2023 — Wolfe Research Initiates Coverage On → Peer Perform 10/09/2023 -6.47% B of A Securities → $65 Initiates Coverage On → Buy 10/09/2023 -10.79% Mizuho → $62 Initiates Coverage On → Buy 10/09/2023 -7.91% Guggenheim → $64 Initiates Coverage On → Buy 10/09/2023 -9.35% TD Cowen → $63 Initiates Coverage On → Outperform 10/09/2023 -7.91% Jefferies

ARM Holdings (NASDAQ:ARM) Analyst Ratings Read Post »

UnitedHealth Group (NYSE:UNH) Analyst Ratings

/ / Health Care /

UnitedHealth Group (NYSE:UNH) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/18/2023 -8.92% HSBC $550 → $480 Downgrades Hold → Reduce 12/13/2023 11% Stephens & Co. → $585 Reiterates Overweight → Overweight 11/30/2023 15.75% Truist Securities → $610 Reiterates Buy → Buy 11/30/2023 13.09% RBC Capital → $596 Reiterates Outperform → Outperform 11/30/2023 11% Stephens & Co. → $585 Reiterates Overweight → Overweight 11/21/2023 12.14% Cantor Fitzgerald → $591 Reiterates Overweight → Overweight 11/20/2023 -4.56% Jefferies $565 → $503 Maintains Hold 10/23/2023 9.87% Morgan Stanley $587 → $579 Maintains Overweight 10/16/2023 13.09% RBC Capital $572 → $596 Maintains Outperform 10/16/2023 10.81% Piper Sandler $580 → $584 Maintains Overweight 10/16/2023 21.44% UBS → $640 Upgrades Neutral → Buy 10/09/2023 0.76% Jefferies $529 → $531 Maintains Hold 09/14/2023 12.14% Cantor Fitzgerald → $591 Reiterates Overweight → Overweight 09/06/2023 2.46% HSBC → $540 Initiates Coverage On

UnitedHealth Group (NYSE:UNH) Analyst Ratings Read Post »

Scroll to Top